1 Prostate Specific Antigen Market Overview 1.1 Product Overview and Scope of Prostate Specific Antigen 1.2 Prostate Specific Antigen Segment by Type 1.2.1 Global Prostate Specific Antigen Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 G-115 1.2.3 INO-5150 1.2.4 ADXS-PSA 1.2.5 AEZS-120 1.2.6 Others 1.3 Prostate Specific Antigen Segment by Application 1.3.1 Prostate Specific Antigen Sales Comparison by Application: (2021-2027) 1.3.2 Prostate Cancer 1.3.3 Metastatic Hormone Refractory Prostate Cancer 1.3.4 Others 1.4 Global Prostate Specific Antigen Market Size Estimates and Forecasts 1.4.1 Global Prostate Specific Antigen Revenue 2016-2027 1.4.2 Global Prostate Specific Antigen Sales 2016-2027 1.4.3 Prostate Specific Antigen Market Size by Region: 2016 Versus 2021 Versus 2027 2 Prostate Specific Antigen Market Competition by Manufacturers 2.1 Global Prostate Specific Antigen Sales Market Share by Manufacturers (2016-2021) 2.2 Global Prostate Specific Antigen Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Prostate Specific Antigen Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Prostate Specific Antigen Manufacturing Sites, Area Served, Product Type 2.5 Prostate Specific Antigen Market Competitive Situation and Trends 2.5.1 Prostate Specific Antigen Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Prostate Specific Antigen Players Market Share by Revenue 2.5.3 Global Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Prostate Specific Antigen Retrospective Market Scenario by Region 3.1 Global Prostate Specific Antigen Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Prostate Specific Antigen Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Prostate Specific Antigen Market Facts & Figures by Country 3.3.1 North America Prostate Specific Antigen Sales by Country 3.3.2 North America Prostate Specific Antigen Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Prostate Specific Antigen Market Facts & Figures by Country 3.4.1 Europe Prostate Specific Antigen Sales by Country 3.4.2 Europe Prostate Specific Antigen Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Prostate Specific Antigen Market Facts & Figures by Region 3.5.1 Asia Pacific Prostate Specific Antigen Sales by Region 3.5.2 Asia Pacific Prostate Specific Antigen Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Prostate Specific Antigen Market Facts & Figures by Country 3.6.1 Latin America Prostate Specific Antigen Sales by Country 3.6.2 Latin America Prostate Specific Antigen Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Prostate Specific Antigen Market Facts & Figures by Country 3.7.1 Middle East and Africa Prostate Specific Antigen Sales by Country 3.7.2 Middle East and Africa Prostate Specific Antigen Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Prostate Specific Antigen Historic Market Analysis by Type 4.1 Global Prostate Specific Antigen Sales Market Share by Type (2016-2021) 4.2 Global Prostate Specific Antigen Revenue Market Share by Type (2016-2021) 4.3 Global Prostate Specific Antigen Price by Type (2016-2021) 5 Global Prostate Specific Antigen Historic Market Analysis by Application 5.1 Global Prostate Specific Antigen Sales Market Share by Application (2016-2021) 5.2 Global Prostate Specific Antigen Revenue Market Share by Application (2016-2021) 5.3 Global Prostate Specific Antigen Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Advaxis, Inc. 6.1.1 Advaxis, Inc. Corporation Information 6.1.2 Advaxis, Inc. Description and Business Overview 6.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Advaxis, Inc. Product Portfolio 6.1.5 Advaxis, Inc. Recent Developments/Updates 6.2 Aeterna Zentaris Inc. 6.2.1 Aeterna Zentaris Inc. Corporation Information 6.2.2 Aeterna Zentaris Inc. Description and Business Overview 6.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Aeterna Zentaris Inc. Product Portfolio 6.2.5 Aeterna Zentaris Inc. Recent Developments/Updates 6.3 Bavarian Nordic A/S 6.3.1 Bavarian Nordic A/S Corporation Information 6.3.2 Bavarian Nordic A/S Description and Business Overview 6.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Bavarian Nordic A/S Product Portfolio 6.3.5 Bavarian Nordic A/S Recent Developments/Updates 6.4 Curevac AG 6.4.1 Curevac AG Corporation Information 6.4.2 Curevac AG Description and Business Overview 6.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Curevac AG Product Portfolio 6.4.5 Curevac AG Recent Developments/Updates 6.5 GenSpera, Inc. 6.5.1 GenSpera, Inc. Corporation Information 6.5.2 GenSpera, Inc. Description and Business Overview 6.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2016-2021) 6.5.4 GenSpera, Inc. Product Portfolio 6.5.5 GenSpera, Inc. Recent Developments/Updates 6.6 Inovio Pharmaceuticals, Inc. 6.6.1 Inovio Pharmaceuticals, Inc. Corporation Information 6.6.2 Inovio Pharmaceuticals, Inc. Description and Business Overview 6.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Inovio Pharmaceuticals, Inc. Product Portfolio 6.6.5 Inovio Pharmaceuticals, Inc. Recent Developments/Updates 6.7 OncBioMune Pharmaceuticals Inc. 6.6.1 OncBioMune Pharmaceuticals Inc. Corporation Information 6.6.2 OncBioMune Pharmaceuticals Inc. Description and Business Overview 6.6.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2016-2021) 6.4.4 OncBioMune Pharmaceuticals Inc. Product Portfolio 6.7.5 OncBioMune Pharmaceuticals Inc. Recent Developments/Updates 7 Prostate Specific Antigen Manufacturing Cost Analysis 7.1 Prostate Specific Antigen Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Prostate Specific Antigen 7.4 Prostate Specific Antigen Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Prostate Specific Antigen Distributors List 8.3 Prostate Specific Antigen Customers 9 Prostate Specific Antigen Market Dynamics 9.1 Prostate Specific Antigen Industry Trends 9.2 Prostate Specific Antigen Growth Drivers 9.3 Prostate Specific Antigen Market Challenges 9.4 Prostate Specific Antigen Market Restraints 10 Global Market Forecast 10.1 Prostate Specific Antigen Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Prostate Specific Antigen by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Prostate Specific Antigen by Type (2022-2027) 10.2 Prostate Specific Antigen Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Prostate Specific Antigen by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Prostate Specific Antigen by Application (2022-2027) 10.3 Prostate Specific Antigen Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Prostate Specific Antigen by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Prostate Specific Antigen by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Prostate Specific Antigen Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Prostate Specific Antigen Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Prostate Specific Antigen Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Prostate Specific Antigen Covered in This Study Table 5. Global Prostate Specific Antigen Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Prostate Specific Antigen Sales Share by Manufacturers (2016-2021) Table 7. Global Prostate Specific Antigen Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Prostate Specific Antigen Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Prostate Specific Antigen Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Prostate Specific Antigen Manufacturing Sites and Area Served Table 11. Manufacturers Prostate Specific Antigen Product Type Table 12. Global Prostate Specific Antigen Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Prostate Specific Antigen by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Prostate Specific Antigen Sales by Region (2016-2021) & (K Pcs) Table 16. Global Prostate Specific Antigen Sales Market Share by Region (2016-2021) Table 17. Global Prostate Specific Antigen Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Prostate Specific Antigen Sales by Country (2016-2021) & (K Pcs) Table 19. North America Prostate Specific Antigen Sales Market Share by Country (2016-2021) Table 20. North America Prostate Specific Antigen Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Prostate Specific Antigen Revenue Market Share by Country (2016-2021) Table 22. Europe Prostate Specific Antigen Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Prostate Specific Antigen Sales Market Share by Country (2016-2021) Table 24. Europe Prostate Specific Antigen Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Prostate Specific Antigen Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Prostate Specific Antigen Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Prostate Specific Antigen Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Prostate Specific Antigen Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Prostate Specific Antigen Revenue Market Share by Region (2016-2021) Table 30. Latin America Prostate Specific Antigen Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Prostate Specific Antigen Sales Market Share by Country (2016-2021) Table 32. Latin America Prostate Specific Antigen Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Prostate Specific Antigen Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Prostate Specific Antigen Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Prostate Specific Antigen Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Prostate Specific Antigen Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Prostate Specific Antigen Revenue Market Share by Country (2016-2021) Table 38. Global Prostate Specific Antigen Sales (K Pcs) by Type (2016-2021) Table 39. Global Prostate Specific Antigen Sales Market Share by Type (2016-2021) Table 40. Global Prostate Specific Antigen Revenue (Million US$) by Type (2016-2021) Table 41. Global Prostate Specific Antigen Revenue Share by Type (2016-2021) Table 42. Global Prostate Specific Antigen Price (USD/Pcs) by Type (2016-2021) Table 43. Global Prostate Specific Antigen Sales (K Pcs) by Application (2016-2021) Table 44. Global Prostate Specific Antigen Sales Market Share by Application (2016-2021) Table 45. Global Prostate Specific Antigen Revenue (Million US$) by Application (2016-2021) Table 46. Global Prostate Specific Antigen Revenue Share by Application (2016-2021) Table 47. Global Prostate Specific Antigen Price (USD/Pcs) by Application (2016-2021) Table 48. Advaxis, Inc. Corporation Information Table 49. Advaxis, Inc. Description and Business Overview Table 50. Advaxis, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Advaxis, Inc. Prostate Specific Antigen Product Table 52. Advaxis, Inc. Recent Developments/Updates Table 53. Aeterna Zentaris Inc. Corporation Information Table 54. Aeterna Zentaris Inc. Description and Business Overview Table 55. Aeterna Zentaris Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Aeterna Zentaris Inc. Prostate Specific Antigen Product Table 57. Aeterna Zentaris Inc. Recent Developments/Updates Table 58. Bavarian Nordic A/S Corporation Information Table 59. Bavarian Nordic A/S Description and Business Overview Table 60. Bavarian Nordic A/S Prostate Specific Antigen Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Bavarian Nordic A/S Prostate Specific Antigen Product Table 62. Bavarian Nordic A/S Recent Developments/Updates Table 63. Curevac AG Corporation Information Table 64. Curevac AG Description and Business Overview Table 65. Curevac AG Prostate Specific Antigen Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Curevac AG Prostate Specific Antigen Product Table 67. Curevac AG Recent Developments/Updates Table 68. GenSpera, Inc. Corporation Information Table 69. GenSpera, Inc. Description and Business Overview Table 70. GenSpera, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. GenSpera, Inc. Prostate Specific Antigen Product Table 72. GenSpera, Inc. Recent Developments/Updates Table 73. Inovio Pharmaceuticals, Inc. Corporation Information Table 74. Inovio Pharmaceuticals, Inc. Description and Business Overview Table 75. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Table 77. Inovio Pharmaceuticals, Inc. Recent Developments/Updates Table 78. OncBioMune Pharmaceuticals Inc. Corporation Information Table 79. OncBioMune Pharmaceuticals Inc. Description and Business Overview Table 80. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Table 82. OncBioMune Pharmaceuticals Inc. Recent Developments/Updates Table 83. Production Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Prostate Specific Antigen Distributors List Table 86. Prostate Specific Antigen Customers List Table 87. Prostate Specific Antigen Market Trends Table 88. Prostate Specific Antigen Growth Drivers Table 89. Prostate Specific Antigen Market Restraints Table 90. Global Prostate Specific Antigen Sales Forecast by Type (2022-2027) & (K Pcs) Table 91. Global Prostate Specific Antigen Sales Market Share Forecast by Type (2022-2027) Table 92. Global Prostate Specific Antigen Revenue Forecast by Type (2022-2027) & (US$ Million) Table 93. Global Prostate Specific Antigen Revenue Market Share Forecast by Type (2022-2027) Table 94. Global Prostate Specific Antigen Sales Forecast by Application (2022-2027) & (K Pcs) Table 95. Global Prostate Specific Antigen Sales Market Share Forecast by Application (2022-2027) Table 96. Global Prostate Specific Antigen Revenue Forecast by Application (2022-2027) & (US$ Million) Table 97. Global Prostate Specific Antigen Revenue Market Share Forecast by Application (2022-2027) Table 98. Global Prostate Specific Antigen Sales Forecast by Region (2022-2027) & (K Pcs) Table 99. Global Prostate Specific Antigen Sales Market Share Forecast by Region (2022-2027) Table 100. Global Prostate Specific Antigen Revenue Forecast by Region (2022-2027) & (US$ Million) Table 101. Global Prostate Specific Antigen Revenue Market Share Forecast by Region (2022-2027) Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Prostate Specific Antigen Figure 2. Global Prostate Specific Antigen Market Share by Type in 2020 & 2027 Figure 3. G-115 Product Picture Figure 4. INO-5150 Product Picture Figure 5. ADXS-PSA Product Picture Figure 6. AEZS-120 Product Picture Figure 7. Others Product Picture Figure 8. Global Prostate Specific Antigen Market Share by Application in 2020 & 2027 Figure 9. Prostate Cancer Figure 10. Metastatic Hormone Refractory Prostate Cancer Figure 11. Others Figure 12. Global Prostate Specific Antigen Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Prostate Specific Antigen Market Size 2016-2027 (US$ Million) Figure 14. Global Prostate Specific Antigen Sales 2016-2027 (K Pcs) Figure 15. Global Prostate Specific Antigen Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Prostate Specific Antigen Sales Share by Manufacturers in 2020 Figure 17. Global Prostate Specific Antigen Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Prostate Specific Antigen Players: Market Share by Revenue in 2020 Figure 19. Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Prostate Specific Antigen Sales Market Share by Region (2016-2021) Figure 21. Global Prostate Specific Antigen Sales Market Share by Region in 2020 Figure 22. Global Prostate Specific Antigen Revenue Market Share by Region (2016-2021) Figure 23. Global Prostate Specific Antigen Revenue Market Share by Region in 2020 Figure 24. U.S. Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E Prostate Specific Antigen Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Prostate Specific Antigen by Type (2016-2021) Figure 49. Sales Market Share of Prostate Specific Antigen by Application (2016-2021) Figure 50. Sales Market Share of Prostate Specific Antigen by Application in 2020 Figure 51. Revenue Share of Prostate Specific Antigen by Application (2016-2021) Figure 52. Revenue Share of Prostate Specific Antigen by Application in 2020 Figure 53. Manufacturing Cost Structure of Prostate Specific Antigen Figure 54. Manufacturing Process Analysis of Prostate Specific Antigen Figure 55. Prostate Specific Antigen Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Advaxis, Inc. Aeterna Zentaris Inc. Bavarian Nordic A/S Curevac AG GenSpera, Inc. Inovio Pharmaceuticals, Inc. OncBioMune Pharmaceuticals Inc.